Jae Hyun Lee

1 day ago | jdsupra.com | Emily Cook |Matthew David |Jae Hyun Lee

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

2 weeks ago | jdsupra.com | Emily Cook |Matthew David |Jae Hyun Lee

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation.

1 month ago | jdsupra.com | Emily Cook |Matthew David |Jae Hyun Lee

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Issues at Stake: Contract Pharmacy; Rebate Model; Other In an appealed case challenging a Louisiana law governing contract pharmacy arrangements, the appellant filed its reply brief.

Jan 16, 2025 | jdsupra.com | Emily Cook |Jae Hyun Lee

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Issues at Stake: Contract Pharmacy; Other In two appealed cases challenging a proposed Louisiana law governing contract pharmacy arrangements, the appellants filed their opening brief.

Dec 6, 2024 | jdsupra.com | Jae Hyun Lee |Steven Schnelle

The 2024 election results will create significant tailwinds for Republican legislative and regulatory priorities in US Congress, federal agencies, and state houses across the country. This On the Subject considers the outlook for pharmacy regulation under the second incoming Trump administration and a unified Republican Congress, as well as state-level pharmacy policies that may advance as Republican public policy momentum builds.